Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients

• Κύριοι συγγραφείς: Paola Montes (Συγγραφέας), Ana Guerra-Librero (Συγγραφέας), Paloma García (Συγγραφέας), María Elena Cornejo-Calvo (Συγγραφέας), María del Señor López (Συγγραφέας), Tomás de Haro (Συγγραφέας), Laura Martínez-Ruiz (Συγγραφέας), Germaine Escames (Συγγραφέας), Darío Acuña-Castroviejo (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

This study focused on the impact of the treatment with the hypomethylating agent 5-azacitidine on the redox status and inflammation in 24 MDS patients. Clinical and genetic features of MDS patients were recorded, and peripheral blood samples were used to determine the activity of the endogenous anti...